159 related articles for article (PubMed ID: 25342374)
41. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients.
Akira M; Hara H; Sakatani M
Radiology; 1999 Feb; 210(2):333-8. PubMed ID: 10207411
[TBL] [Abstract][Full Text] [Related]
42. Cyclophosphamide pulse therapy for rapidly progressive interstitial pneumonia in dermatomyositis. A new possibility for rescue?
Takizawa H; Ito K
Intern Med; 1997 Jul; 36(7):448-9. PubMed ID: 9240490
[No Abstract] [Full Text] [Related]
43. Pulmonary complications of polymyositis and dermatomyositis.
Fathi M; Lundberg IE; Tornling G
Semin Respir Crit Care Med; 2007 Aug; 28(4):451-8. PubMed ID: 17764062
[TBL] [Abstract][Full Text] [Related]
44. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment.
Schnabel A; Reuter M; Biederer J; Richter C; Gross WL
Semin Arthritis Rheum; 2003 Apr; 32(5):273-84. PubMed ID: 12701038
[TBL] [Abstract][Full Text] [Related]
45. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis.
Gono T; Kawaguchi Y; Hara M; Masuda I; Katsumata Y; Shinozaki M; Ota Y; Ozeki E; Yamanaka H
Rheumatology (Oxford); 2010 Jul; 49(7):1354-60. PubMed ID: 20385617
[TBL] [Abstract][Full Text] [Related]
46. [Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
Bartosiewicz M; Siemion-Szcześniak I; Sobiecka M; Wyrostkiewicz D; Radwan-Röhrenschef P; Lewandowska K; Langfort R; Oniszh K; Franczuk M; Kuś J
Pneumonol Alergol Pol; 2013; 81(6):556-66. PubMed ID: 24142786
[TBL] [Abstract][Full Text] [Related]
47. [Dermatomyositis and polymyositis: clinical aspects and treatment].
Hachulla E
Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
[TBL] [Abstract][Full Text] [Related]
48. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
[TBL] [Abstract][Full Text] [Related]
49. Antisynthetase syndrome: not just an inflammatory myopathy.
Chatterjee S; Prayson R; Farver C
Cleve Clin J Med; 2013 Oct; 80(10):655-66. PubMed ID: 24085811
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study.
Nakazawa M; Kaneko Y; Takeuchi T
Clin Rheumatol; 2018 Mar; 37(3):765-771. PubMed ID: 28975463
[TBL] [Abstract][Full Text] [Related]
51. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
[TBL] [Abstract][Full Text] [Related]
52. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis.
Yokoyama Y; Furuta S; Ikeda K; Hirose K; Nakajima H
Mod Rheumatol; 2015; 25(6):888-92. PubMed ID: 25775144
[TBL] [Abstract][Full Text] [Related]
53. Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
Tsuchiya H; Tsuno H; Inoue M; Takahashi Y; Yamashita H; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):694-6. PubMed ID: 24506658
[No Abstract] [Full Text] [Related]
54. Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis/polymyositis: a retrospective study.
Takada K; Kishi J; Miyasaka N
Mod Rheumatol; 2007; 17(2):123-30. PubMed ID: 17437167
[TBL] [Abstract][Full Text] [Related]
55. [Successful therapy with cyclosporine in a case with interstitial pneumonitis associated with polymyositis].
Soga T; Hagiwara E; Shirai A; Igarashi T; Ishigatsubo Y; Okubo T
Nihon Rinsho Meneki Gakkai Kaishi; 1996 Apr; 19(2):157-62. PubMed ID: 8705693
[TBL] [Abstract][Full Text] [Related]
56. Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report.
Yamada K; Asai K; Okamoto A; Watanabe T; Kanazawa H; Ohata M; Ohsawa M; Hirata K
BMC Res Notes; 2018 Jan; 11(1):34. PubMed ID: 29338781
[TBL] [Abstract][Full Text] [Related]
57. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis.
Miyake S; Ohtani Y; Sawada M; Inase N; Miyazaki Y; Takano S; Miyasaka N; Yoshizawa Y
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):128-33. PubMed ID: 12102608
[TBL] [Abstract][Full Text] [Related]
58. Impact of the Combined Immunosuppressive Therapy on Different Mortality Score Groups in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease and the Problem of Sample Splitting.
Waki D; Nishimura K
Chest; 2021 Feb; 159(2):882-883. PubMed ID: 33563444
[No Abstract] [Full Text] [Related]
59. Anti-Ro 52 positive dermatomyositis presenting as rapidly progressive interstitial lung disease.
Conway R; O'Donnell R; Fahy R; Doran MF; Cunnane G; O'Shea FD
QJM; 2014 Jul; 107(7):593-4. PubMed ID: 24336848
[No Abstract] [Full Text] [Related]
60. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
Harigai M; Hara M; Kamatani N; Kashiwazaki S
Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
